1. Home
  2. TECX vs SKYH Comparison

TECX vs SKYH Comparison

Compare TECX & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • SKYH
  • Stock Information
  • Founded
  • TECX 2019
  • SKYH 2017
  • Country
  • TECX United States
  • SKYH United States
  • Employees
  • TECX N/A
  • SKYH N/A
  • Industry
  • TECX
  • SKYH Military/Government/Technical
  • Sector
  • TECX
  • SKYH Industrials
  • Exchange
  • TECX Nasdaq
  • SKYH Nasdaq
  • Market Cap
  • TECX 334.4M
  • SKYH 325.2M
  • IPO Year
  • TECX 2018
  • SKYH N/A
  • Fundamental
  • Price
  • TECX $21.34
  • SKYH $9.95
  • Analyst Decision
  • TECX Buy
  • SKYH Strong Buy
  • Analyst Count
  • TECX 6
  • SKYH 3
  • Target Price
  • TECX $78.67
  • SKYH $14.83
  • AVG Volume (30 Days)
  • TECX 241.7K
  • SKYH 196.5K
  • Earning Date
  • TECX 08-13-2025
  • SKYH 08-12-2025
  • Dividend Yield
  • TECX N/A
  • SKYH N/A
  • EPS Growth
  • TECX N/A
  • SKYH N/A
  • EPS
  • TECX N/A
  • SKYH N/A
  • Revenue
  • TECX N/A
  • SKYH $17,950,000.00
  • Revenue This Year
  • TECX N/A
  • SKYH $122.85
  • Revenue Next Year
  • TECX N/A
  • SKYH $45.30
  • P/E Ratio
  • TECX N/A
  • SKYH N/A
  • Revenue Growth
  • TECX N/A
  • SKYH 102.32
  • 52 Week Low
  • TECX $13.70
  • SKYH $8.26
  • 52 Week High
  • TECX $61.07
  • SKYH $14.52
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.82
  • SKYH 45.64
  • Support Level
  • TECX $19.13
  • SKYH $9.57
  • Resistance Level
  • TECX $21.46
  • SKYH $9.92
  • Average True Range (ATR)
  • TECX 1.27
  • SKYH 0.31
  • MACD
  • TECX -0.00
  • SKYH 0.07
  • Stochastic Oscillator
  • TECX 70.50
  • SKYH 59.79

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

Share on Social Networks: